Kronox Lab Share Price & Earnings Call Analysis

Financials of Kronox Lab

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Kronox Lab

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +21.4725.9521.0220.7122.1825.1924.8624.0126.1324.2925.5325.2726.13
Expenses +17.4817.4315.1614.6314.3316.9816.0615.6518.3816.3216.8817.2416.61
Operating Profit3.998.525.866.087.858.218.808.367.757.978.658.039.52
OPM %18.58%32.83%27.88%29.36%35.39%32.59%35.40%34.82%29.66%32.81%33.88%31.78%36.43%
Other Income +0.140.240.490.020.830.430.360.820.910.871.041.132.15
Interest0.000.000.000.000.000.000.000.000.000.000.040.040.04
Depreciation0.300.320.380.300.290.330.340.360.350.400.470.520.66
Profit before tax3.838.445.975.808.398.318.828.828.318.449.188.6010.97
Tax %36.55%24.53%27.14%18.28%29.92%25.99%26.64%26.08%24.07%25.71%27.23%23.37%26.98%
Net Profit +2.446.384.354.745.886.156.476.536.326.286.686.598.00
EPS in Rs0.661.721.171.281.581.661.741.761.701.691.801.782.16

Financials of Kronox Lab

Profit & Loss

Annual income statement trend

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +5062829690100101
Expenses +39486374626767
Operating Profit12152022283334
OPM %23%24%24%23%32%33%34%
Other Income +1112235
Interest0000000
Depreciation1222112
Profit before tax12131822293437
Tax %27%26%26%26%25%26%26%
Net Profit +9101416212528
EPS in Rs343.60403.73565.564.425.756.867.45
Dividend Payout %0%0%0%0%9%7%7%

Financials of Kronox Lab

Balance Sheet

Capital structure and asset base

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.250.240.2437373737
Reserves2327408295379
Borrowings +0430002
Other Liabilities +1171398910
Total Liabilities343857547499128
Fixed Assets +691116262829
CWIP0000011
Investments0000000
Other Assets +29284538477098
Total Assets343857547499128

Financials of Kronox Lab

Cash Flows

Operating, investing and financing cash movement

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +411920173124
Cash from Investing Activity +-4-3-8-7-17-28-24
Cash from Financing Activity +-0-7-1-130-2-0
Net Cash Flow011-000-0
Free Cash Flow31051152821
CFO/OP65%100%70%117%87%120%98%

Financials of Kronox Lab

Ratios

Working capital efficiency and return ratios

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1109011471727276
Inventory Days70585861744666
Days Payable102698952515252
Cash Conversion Cycle78798480946690
Working Capital Days100951228314316871
ROCE %50%51%50%52%44%36%

Continue your research

Others in Chemicals & Petrochemicals this season

  • Solar Industries India Ltd (Q1 FY27)

    EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…

  • Sudarshan Chemical Industries Ltd (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Chemicals Ltd (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF Ltd (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

Compare:vs Solar Industries India Ltdvs Pidilite Industries Ltdvs SRF Ltd